Semaglutide at a glance
| Detail | What the sources say |
|---|---|
| Brands (Novo Nordisk) | Ozempic® and Rybelsus® (type 2 diabetes); Wegovy® (weight management) |
| Forms | Weekly injection pens; daily tablets |
| Other approved uses | Cardiovascular risk reduction in specific groups; MASH with liver fibrosis (Wegovy®, 2025) |
| Research-market products | The FDA has warned sellers of unapproved semaglutide labelled “for research purposes” or “not for human consumption” |
| Where approved | US (FDA) and EU (EMA), among others |
From the label to the app
| What the label says | What PepLabo does with it |
|---|---|
| Ozempic®: a missed dose within 5 days, otherwise skip it [1]. Wegovy® injection: give it if the next dose is more than 48 hours away [2]. | Each brand is its own product in PepLabo, so the right leaflet always matches the right log. |
| Tablets: empty stomach in the morning, up to 4 ounces of water, then at least 30 minutes before food or drink [3]. | Set a morning reminder at the time you choose; each log saves the exact time you took it. There is no 30-minute timer. |
| Injections: rotate the site with each dose [2]. | Each log asks for the site on a front and back body map, and a weekly heat map shows which areas you used. |
What PepLabo does and does not do
| PepLabo does | PepLabo does not |
|---|---|
| Record each dose with the date, time and amount you enter, and the site for injections | Suggest a dose, a schedule change or a medicine |
| Remind you 15 minutes before, at the dose time, and 30 minutes after a missed dose | Tell you what to do after a missed dose; the leaflet and your prescriber do |
| Put check-ins, weight and doses on one timeline | Interpret symptoms or judge progress |
| Keep your records on your phone, with no account needed to track | Use analytics, advertising or tracking SDKs, or write to Apple Health |
| Create a PDF of your dose log for your clinician (Pro) | Replace your clinician or pharmacist |
